These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1578480)

  • 61. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones.
    Allen TG; Brown DA
    J Physiol; 1993 Jul; 466():173-89. PubMed ID: 8410690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
    Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intestinal epithelial cells and musculature contain different muscarinic binding sites.
    Tien XY; Wahawisan R; Wallace LJ; Gaginella TS
    Life Sci; 1985 May; 36(20):1949-55. PubMed ID: 3838790
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of histamine release and synthesis in the brain by muscarinic receptors.
    Gulat-Marnay C; Lafitte A; Arrang JM; Schwartz JC
    J Neurochem; 1989 Jan; 52(1):248-54. PubMed ID: 2462019
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission.
    Aramakis VB; Bandrowski AE; Ashe JH
    Synapse; 1999 Jun; 32(4):262-75. PubMed ID: 10332802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of cholinergic muscarinic receptors in the rabbit iris.
    Honkanen RE; Abdel-Latif AA
    Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain.
    Messer WS; Ngur DO; Abuh YF; Dokas LA; Ting SM; Hacksell U; Nilsson BM; Dunbar PG; Hoss W
    Chirality; 1992; 4(8):463-8. PubMed ID: 1476855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P; Ebinger G; Vauquelin G
    Biochem Pharmacol; 1987 Dec; 36(23):4119-24. PubMed ID: 3689439
    [TBL] [Abstract][Full Text] [Related]  

  • 71. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
    Zhou LW; Zhang SP; Connell TA; Weiss B
    J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
    Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heterocyclic muscarinic agonists. Synthesis and biological activity of some bicyclic sulfonium arecoline bioisosteres.
    Sauerberg P; Falch E; Meier E; Lembøl HL; Krogsgaard-Larsen P
    J Med Chem; 1988 Jul; 31(7):1312-6. PubMed ID: 3385727
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors.
    Gies JP; Landry Y
    Biochem Biophys Res Commun; 1988 Jan; 150(2):673-80. PubMed ID: 3342042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Different effects of N-ethylmaleimide on M1 and M2 muscarine receptors in rat brain.
    Flynn DD; Potter LT
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):580-3. PubMed ID: 3855569
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis.
    Ogane N; Takada Y; Iga Y; Kawanishi G; Mizobe F
    Neurosci Lett; 1990 Jun; 114(1):95-100. PubMed ID: 2381577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An M3-like muscarinic autoreceptor regulates the in vivo release of acetylcholine in rat striatum.
    De Boer P; Westerink BH; Rollema H; Zaagsma J; Horn AS
    Eur J Pharmacol; 1990 Apr; 179(1-2):167-72. PubMed ID: 2364978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.